Icon (ICLR) Long-Term Deferred Tax (2009 - 2026)
Icon's (ICLR) quarterly Long-Term Deferred Tax came in at $107.4 million in Q2 2026, up 24.5% year-over-year from $86.3 million in Q2 2025, and down 1.85% quarter-over-quarter from $109.4 million in Q1 2026.
Analysis
Icon (ICLR) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Long-Term Deferred Tax for 18 consecutive years, with $107.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Long-Term Deferred Tax rose 24.5% year-over-year to $107.4 million in Q2 2026; TTM through Jun 2026 was $107.4 million, a 24.5% increase from a year earlier, with the FY2025 full-year figure at $106.9 million, up 24.45% from the prior year.
- Long-Term Deferred Tax was $107.4 million for Q2 2026 at Icon, down from $109.4 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $109.4 million in Q1 2026 and troughed at $54.1 million in Q2 2022.
- A 5-year average of $83.0 million and a median of $81.9 million in 2023 frame the typical range for Long-Term Deferred Tax.
- The widest YoY moves for Long-Term Deferred Tax: up 340.08% in 2022, down 46.9% in 2022.
- Over 5 years, Long-Term Deferred Tax stood at $98.1 million in 2022, then decreased by 25.75% to $72.9 million in 2023, then grew by 17.87% to $85.9 million in 2024, then grew by 24.45% to $106.9 million in 2025, then climbed by 0.5% to $107.4 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $107.4 million (Q2 2026), $109.4 million (Q1 2026), and $106.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.41 Mn |
| Mar 31, 2026 | 109.44 Mn |
| Dec 31, 2025 | 106.87 Mn |
| Sep 30, 2025 | 100.81 Mn |
| Jun 30, 2025 | 86.28 Mn |
| Mar 31, 2025 | 77.40 Mn |
| Dec 31, 2024 | 85.88 Mn |
| Sep 30, 2024 | 75.99 Mn |
| Jun 30, 2024 | 74.79 Mn |
| Mar 31, 2024 | 74.78 Mn |
| Dec 31, 2023 | 72.86 Mn |
| Sep 30, 2023 | 83.10 Mn |
| Jun 30, 2023 | 80.77 Mn |
| Mar 31, 2023 | 89.41 Mn |
| Dec 31, 2022 | 98.12 Mn |
| Sep 30, 2022 | 62.30 Mn |
| Jun 30, 2022 | 54.05 Mn |
| Mar 31, 2022 | 54.36 Mn |
| Dec 31, 2021 | 100.04 Mn |
| Sep 30, 2021 | 117.31 Mn |